Literature DB >> 28605503

Behavioural, not biological, factors drive the HCV epidemic among HIV-positive MSM: HCV and HIV modelling analysis including HCV treatment-as-prevention impact.

Louis MacGregor1, Natasha K Martin1,2, Christinah Mukandavire1, Ford Hickson3, Peter Weatherburn3, Matthew Hickman1, Peter Vickerman1.   

Abstract

Background: Uncertainty surrounds why hepatitis C virus (HCV) is concentrated among HIV-positive men who have sex with men (MSM). We used mathematical modelling to explore reasons for these infection patterns, and implications for HCV treatment-as-prevention.
Methods: Using a joint MSM HIV/HCV transmission model parameterized with UK behavioural data, we considered how biological (heightened HCV infectivity and reduced spontaneous clearance among HIV-positive MSM) and/or behavioural factors (preferential sexual mixing by HIV status and risk heterogeneity) could concentrate HCV infection in HIV-positive MSM as commonly observed (5-20 times the HCV prevalence in HIV-negative MSM; defined as the HCV ratio). We explored how HCV treatment-as-prevention impact varies under differing HCV ratios.
Results: Biological factors produced low HCV ratios (< 3), not explaining the skewed epidemic. However, combining preferential mixing by HIV status with sexual risk behaviour heterogeneity produced high HCV ratios (> 10) that were highly sensitive to both factors. Irrespective of the HCV ratio or behavioural/biological factors, HCV treatment of HIV-diagnosed MSM markedly reduced the HCV prevalence among HIV-positive MSM, but less impact was achieved among all MSM for lower HCV ratios. Conclusions: Sexual behaviour patterns likely drive observed HCV infection patterns among HIV-positive MSM. Changes in these patterns could disseminate HCV amongst HIV-negative MSM, limiting the impact of targeting HCV treatment to HIV-diagnosed MSM.
© The Author 2017; all rights reserved. Published by Oxford University Press on behalf of the International Epidemiological Association

Entities:  

Keywords:  HIV; Hepatitis C virus; antiviral treatment; men who have sex with men; prevention

Mesh:

Year:  2017        PMID: 28605503      PMCID: PMC5837478          DOI: 10.1093/ije/dyx075

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  46 in total

1.  Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action. Concerted Action on SeroConversion to AIDS and Death in Europe.

Authors: 
Journal:  Lancet       Date:  2000-04-01       Impact factor: 79.321

Review 2.  Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples.

Authors:  Andrew Anglemyer; George W Rutherford; Rachel C Baggaley; Matthias Egger; Nandi Siegfried
Journal:  Cochrane Database Syst Rev       Date:  2011-08-10

3.  Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study.

Authors:  Janaki Amin; Matthew G Law; Mark Bartlett; John M Kaldor; Gregory J Dore
Journal:  Lancet       Date:  2006-09-09       Impact factor: 79.321

4.  Determinants of the quantity of hepatitis C virus RNA.

Authors:  D L Thomas; J Astemborski; D Vlahov; S A Strathdee; S C Ray; K E Nelson; N Galai; K R Nolt; O Laeyendecker; J A Todd
Journal:  J Infect Dis       Date:  2000-03       Impact factor: 5.226

Review 5.  Sexually transmitted hepatitis C infection: the new epidemic in MSM?

Authors:  Daniel Bradshaw; Gail Matthews; Mark Danta
Journal:  Curr Opin Infect Dis       Date:  2013-02       Impact factor: 4.915

6.  Factors associated with spontaneous clearance of hepatitis C virus among illicit drug users.

Authors:  Jason Grebely; Jesse D Raffa; Calvin Lai; Mel Krajden; Brian Conway; Mark W Tyndall
Journal:  Can J Gastroenterol       Date:  2007-07       Impact factor: 3.522

Review 7.  Meta-analysis of the efficacy and safety of sofosbuvir for the treatment of hepatitis C virus infection.

Authors:  Hye Jin Yang; Ju Yeon Ryoo; Bong Kyu Yoo
Journal:  Int J Clin Pharm       Date:  2015-06-06

8.  Hepatitis C virus transmission among human immunodeficiency virus-infected men who have sex with men: Modeling the effect of behavioral and treatment interventions.

Authors:  Luisa Salazar-Vizcaya; Roger D Kouyos; Cindy Zahnd; Gilles Wandeler; Manuel Battegay; Katharine Elizabeth Anna Darling; Enos Bernasconi; Alexandra Calmy; Pietro Vernazza; Hansjakob Furrer; Matthias Egger; Olivia Keiser; Andri Rauch
Journal:  Hepatology       Date:  2016-10-19       Impact factor: 17.425

9.  HIV incidence in men who have sex with men in England and Wales 2001-10: a nationwide population study.

Authors:  Paul J Birrell; O Noel Gill; Valerie C Delpech; Alison E Brown; Sarika Desai; Tim R Chadborn; Brian D Rice; Daniela De Angelis
Journal:  Lancet Infect Dis       Date:  2013-02-01       Impact factor: 25.071

10.  Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy.

Authors:  Margaret T May; Mark Gompels; Valerie Delpech; Kholoud Porter; Chloe Orkin; Stephen Kegg; Phillip Hay; Margaret Johnson; Adrian Palfreeman; Richard Gilson; David Chadwick; Fabiola Martin; Teresa Hill; John Walsh; Frank Post; Martin Fisher; Jonathan Ainsworth; Sophie Jose; Clifford Leen; Mark Nelson; Jane Anderson; Caroline Sabin
Journal:  AIDS       Date:  2014-05-15       Impact factor: 4.177

View more
  11 in total

1.  The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling study.

Authors:  Adam Trickey; Hannah Fraser; Aaron G Lim; Amy Peacock; Samantha Colledge; Josephine G Walker; Janni Leung; Jason Grebely; Sarah Larney; Natasha K Martin; Matthew Hickman; Louisa Degenhardt; Margaret T May; Peter Vickerman
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-04-10

2.  Eliminating Hepatitis C Virus Among Human Immunodeficiency Virus-Infected Men Who Have Sex With Men in Berlin: A Modeling Analysis.

Authors:  Natasha K Martin; Klaus Jansen; Matthias An der Heiden; Christoph Boesecke; Anders Boyd; Knud Schewe; Axel Baumgarten; Thomas Lutz; Stefan Christensen; Alexander Thielen; Stefan Mauss; Jürgen K Rockstroh; Britt Skaathun; Patrick Ingiliz
Journal:  J Infect Dis       Date:  2019-10-08       Impact factor: 5.226

3.  Are we on the precipice of a new epidemic? Risk for hepatitis C among HIV-negative men-, trans women-, and trans men- who have sex with men in the United States.

Authors:  Christian Grov; Drew A Westmoreland; Adam W Carrico; Denis Nash
Journal:  AIDS Care       Date:  2020-03-15

4.  The cost-effectiveness of case-finding strategies for achieving hepatitis C elimination among men who have sex with men in the UK.

Authors:  Louis Macgregor; Zoe Ward; Natasha K Martin; Jane Nicholls; Monica Desai; Ford Hickson; Peter Weatherburn; Matthew Hickman; Peter Vickerman
Journal:  J Viral Hepat       Date:  2021-04-01       Impact factor: 3.517

5.  Combination interventions for Hepatitis C and Cirrhosis reduction among people who inject drugs: An agent-based, networked population simulation experiment.

Authors:  Bilal Khan; Ian Duncan; Mohamad Saad; Daniel Schaefer; Ashly Jordan; Daniel Smith; Alan Neaigus; Don Des Jarlais; Holly Hagan; Kirk Dombrowski
Journal:  PLoS One       Date:  2018-11-29       Impact factor: 3.240

6.  Global Burden and Changing Trend of Hepatitis C Virus Infection in HIV-Positive and HIV-Negative MSM: A Systematic Review and Meta-Analysis.

Authors:  Yang Zheng; Meike Ying; Yuqing Zhou; Yushi Lin; Jingjing Ren; Jie Wu
Journal:  Front Med (Lausanne)       Date:  2021-12-13

7.  Hepatitis B, C, and D virus and human T-cell leukemia virus types 1 and 2 infections and correlates among men who have sex with men in Ouagadougou, Burkina Faso.

Authors:  Henri Gautier Ouedraogo; Seni Kouanda; Ashley Grosso; Rebecca Compaoré; Modibo Camara; Charlemagne Dabire; Rasmata Ouedraogo; Yves Traore; Stefan Baral; Nicolas Barro
Journal:  Virol J       Date:  2018-12-29       Impact factor: 4.099

8.  Hepatitis C Screening in Community-Based Voluntary Counselling and Testing Services in Europe: An Observational Study from the COBATEST Network 2014-2018.

Authors:  Anna Conway; Laura Fernàndez-López; Juliana Reyes-Urueña; Jordi Casabona
Journal:  J Community Health       Date:  2020-06

9.  Scaling up screening and treatment for elimination of hepatitis C among men who have sex with men in the era of HIV pre-exposure prophylaxis.

Authors:  Louis Macgregor; Monica Desai; Natasha K Martin; Jane Nicholls; Ford Hickson; Peter Weatherburn; Matthew Hickman; Peter Vickerman
Journal:  EClinicalMedicine       Date:  2019-12-19

10.  What is needed to achieve HCV microelimination among HIV-infected populations in Andalusia, Spain: a modeling analysis.

Authors:  Britt Skaathun; Annick Borquez; Antonio Rivero-Juarez; Sanjay R Mehta; Francisco Tellez; Manuel Castaño-Carracedo; Dolores Merino; Rosario Palacios; Juan Macías; Antonio Rivero; Natasha K Martin
Journal:  BMC Infect Dis       Date:  2020-08-08       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.